Literature DB >> 10457213

Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice.

A M Buisman1, T L Van Zwet, J A Langermans, M F Geertsma, P J Leenen, R van Furth.   

Abstract

In the present study, the effect of treatment with granulocyte colony-stimulating factor (G-CSF) on cellular composition of the bone marrow and the number of circulating leucocytes of granulocytopenic mice, whether or not infected with Staphylococcus aureus, was assessed. With two monoclonal antibodies, six morphologically distinct cell populations in the bone marrow could be characterised and quantitated by two-dimensional flow cytometry. Granulocytopenia was induced by cyclophosphamide or sublethal irradiation. Cyclophosphamide predominantly affected the later stages of dividing cells in the bone marrow resulting in a decrease in number of granulocytic cells, monocytic cells, lymphoid cells and myeloid blasts. G-CSF administration to cyclophosphamide-treated mice increased the number of early blasts, myeloid blasts and granulocytic cells in the bone marrow, which indicates that this growth factor stimulates the proliferation of these cells in the bone marrow. During infection in cyclophosphamide-treated mice the number of myeloid blasts increased. However, when an infection was induced in cyclophosphamide and G-CSF-treated mice, the proliferation of bone-marrow cells was not changed compared to that in noninfected similarly treated mice. Sublethal irradiation affected all bone-marrow cell populations, including the early blasts. G-CSF-treatment of irradiated mice increased only the number of myeloid blasts slightly, whereas an infection in irradiated mice, whether or not treated with G-CSF, did not affect the number of bone-marrow cells. Together, these studies demonstrated that irradiation affects the early blasts and myeloid blasts in the bone marrow more severely than treatment with cyclophosphamide. Irradiation probably depletes the bone marrow from G-CSF-responsive cells, while cyclophosphamide spared G-CSF responsive cells, thus enabling the enhanced G-CSF-mediated recovery after cyclophosphamide treatment. Only in these mice, bone marrow recovery is followed by a strong mobilisation of mature granulocytes and their band forms from the bone marrow into the circulation during a bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457213      PMCID: PMC2326870          DOI: 10.1046/j.1365-2567.1999.00835.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Influence of dose on regeneration of murine hematopoietic stem cells after total body irradiation and 5-fluorouracil.

Authors:  M Høyer; O S Nielsen
Journal:  Oncology       Date:  1992       Impact factor: 2.935

2.  Late effects of single and repeated sublethal gamma radiations on haemopoietic stem cells in mice.

Authors:  J Vávrová; P Petýrek
Journal:  Folia Biol (Praha)       Date:  1986       Impact factor: 0.906

3.  Quantitative studies of blood and bone marrow neutrophils in normal mice.

Authors:  P A Chervenick; D R Boggs; J C Marsh; G E Cartwright; M M Wintrobe
Journal:  Am J Physiol       Date:  1968-08

4.  Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens.

Authors:  P J Leenen; M Melis; W A Slieker; W Van Ewijk
Journal:  Eur J Immunol       Date:  1990-01       Impact factor: 5.532

5.  A cell-kinetics model for radiation-induced myelopoiesis.

Authors:  T D Jones; M D Morris; R W Young; R A Kehlet
Journal:  Exp Hematol       Date:  1993-06       Impact factor: 3.084

6.  Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.

Authors:  S Tanikawa; I Nakao; K Tsuneoka; N Nara
Journal:  Exp Hematol       Date:  1989-09       Impact factor: 3.084

7.  Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination.

Authors:  K G Waddick; C W Song; L Souza; F M Uckun
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

8.  Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor.

Authors:  S Neben; K Marcus; P Mauch
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

9.  Kinetics of rG-CSF-induced neutrophilia in mice.

Authors:  T Uchida; A Yamagiwa
Journal:  Exp Hematol       Date:  1992-02       Impact factor: 3.084

10.  Bone marrow cellular composition in Listeria monocytogenes infected mice detected using ER-MP12 and ER-MP20 antibodies: a flow cytometric alternative to differential counting.

Authors:  M F de Bruijn; W van Vianen; R E Ploemacher; I A Bakker-Woudenberg; P A Campbell; W van Ewijk; P J Leenen
Journal:  J Immunol Methods       Date:  1998-08-01       Impact factor: 2.303

View more
  3 in total

1.  Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis.

Authors:  A Garcia; J P Adler-Moore; R T Proffitt
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 2.  Chinese herbal medicine for myelosuppression induced by chemotherapy or radiotherapy: a systematic review of randomized controlled trials.

Authors:  Youji Jia; Huihui Du; Min Yao; Xuejun Cui; Qi Shi; Yongjun Wang; Yanping Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

3.  Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice.

Authors:  Marek Fol; Marcin Włodarczyk; Magdalena Kowalewicz-Kulbat; Magdalena Druszczyńska; Krzysztof T Krawczyk; Sebastian Wawrocki; Wiesława Rudnicka; Magdalena Chmiela
Journal:  Vaccines (Basel)       Date:  2022-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.